Active, Not Recruiting
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
NCT03979131
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastroesophageal Junction Adenocarcinoma, +6 more
- Locations
-
- Vall d'Hebron Institute of Oncology Barcelona, Spain